Is Nexium 24HR just a lower dose of Nexium?

No. Nexium 24HR is 20 mg, and the prescription capsules come in 20 mg and 40 mg, so the same 20 mg exists on both sides. The difference is in the approvals: a 14-day course for frequent heartburn in adults, against a list of conditions treated for durations set per indication.

Can the over-the-counter version be taken long term?

Its label does not authorise that. It sets 14 days, once daily, and says not to use it for more than 14 days or to take more than one course every four months unless a doctor directs it.

Which one is stronger?

That question does not have a label answer. The active ingredient is the same and the over-the-counter strength matches the lower prescription strength. What differs is how long it may be taken and for what.

Comparison

Nexium vs Nexium 24HR

Nexium

ESOMEPRAZOLE MAGNESIUM

Approved forGERD, erosive oesophagitis, ulcers

Covers heartburn

AstraZeneca Pharmaceuticals LPLabel version 74, effective 19 December 2025

Nexium 24HR

ESOMEPRAZOLE MAGNESIUM

Approved forFrequent heartburn, as a 14-day course

Covers heartburn

Haleon US Holdings LLCLabel version 30, effective 19 March 2024

Each stripe is one section of the label, each division in a stripe one entry in that section.

Reference information, not medical advice

This page is a reference, not medical advice. It reports what the FDA-approved label states and links to that label. It does not tell anyone what to take, and it cannot replace a conversation with a doctor or pharmacist who knows the person's history.

Nexium and Nexium 24HR contain the same active ingredient, esomeprazole magnesium, and hold two separate FDA approvals. The difference between them is not strength. It is who decides how long the medicine is taken, and for what.

Side by side, straight from the labels

From the FDA label

This table is generated from the two source labels, not typed out by hand, so it cannot drift from what the regulator approved.

Label section	NexiumESOMEPRAZOLE MAGNESIUM	Nexium 24HRESOMEPRAZOLE MAGNESIUM
Active ingredient	EsomeprazoleProton pump inhibitor	EsomeprazoleProton pump inhibitor
Approved for	GERD, erosive oesophagitis, ulcers	Frequent heartburn, as a 14-day course
Supply	Prescription	Over the counter
What pharmacies payAcquisition cost, not retail	$9.14 per tablet, capsule or pen, brand	not listed
Boxed warning	None	None
What the FDA approved it for	Maintenance of healing of EE in adults. Short-term treatment of heartburn and other symptoms associated GERD in adults and pediatric patients 12 years to 17 years of age. Risk reduction of nonsteroidal anti-inflammatory drugs (NSAID)-associated gastric ulcer in adults at risk for developing gastric ulcers due to age (60 years and older) and/or documented history of gastric ulcers. Helicobacter pylori eradication in adult patients to reduce the risk of duodenal ulcer recurrence in combination with amoxicillin and clarithromycin. Long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome in adults. NEXIUM for delayed-release oral suspension is indicated for the: Short-term treatment in the healing of EE in pediatric patients 1 year to 11 years of age and of EE due to acid-mediated GERD in pediatric patients 1 month to less than 1 year of age.	Acid reducer treats frequent heartburn (occurs 2 or more days a week) not intended for immediate relief of heartburn; this drug may take 1 to 4 days for full effect
Forms and strengths	Delayed-Release Capsules: 20 mg and 40 mg esomeprazole. For Delayed-Release Oral Suspension: 2.5 mg, 5 mg, 10 mg, 20 mg, and 40 mg esomeprazole.	Esomeprazole 20 mg (Each delayed-release capsule corresponds to 22.3 mg esomeprazole magnesium trihydrate)
How the label says it is taken	Population Recommended Adult and Pediatric Dosage Healing of EE (1 year and older) EE due to Acid-Mediated GERD (1 month to less than 1 year) Adults 20 mg or 40 mg A maximum dosage of 20 mg once daily is recommended for patients with severe liver impairment (Child-Pugh Class C). once daily for 4 to 8 weeks; Swallow capsules whole; do not crush or chew. For patients who cannot swallow intact capsule, the capsule can be opened, and the contents mixed with applesauce. Mix packets with water to create an oral suspension. Opened capsules can be administered through a nasogastric tube and oral suspension can be administered through a nasogastric or gastric tube. Recommended Dosage in Adults by Indication Table 1 shows the recommended adult dosage of NEXIUM by indication.	adults 18 years of age and older this product is to be used once a day (every 24 hours), every day for 14 days may take 1 to 4 days for full effect 14-Day Course of Treatment Repeated 14-Day Courses (if needed) swallow 1 capsule with a glass of water before eating in the morning take every day for 14 days do not take more than 1 capsule a day swallow whole. Do not crush or chew capsules. do not use for more than 14 days unless directed by your doctor you may repeat a 14-day course every 4 months do not take for more than 14 days or more often than every 4 months unless directed by a doctor children under 18 years of age: ask a doctor before use. Heartburn in children may sometimes be caused by a serious condition.
Most common adverse reactions	Most common adverse reactions: • Adults (≥ 18 years) (> 1%) are: headache, diarrhea, nausea, flatulence, abdominal pain, constipation, and dry mouth. most common adverse reactions that were reported were: diarrhea (4%), headache (4%), and abdominal pain (4%).	your heartburn continues or worsens you need to take this product for more than 14 days you need to take more than 1 course of treatment every 4 months you get diarrhea you develop a rash or joint pain
Warnings and precautions	Gastric Malignancy: In adults, symptomatic response does not preclude the presence of gastric malignancy. Consider additional follow-up and diagnostic testing. Acute Tubulointerstitial Nephritis: Discontinue treatment and evaluate patients. Clostridium difficile- Associated Diarrhea: PPI therapy may be associated with increased risk. Bone Fracture: Long-term and multiple daily dose PPI therapy may be associated with an increased risk for osteoporosis-related fractures of the hip, wrist or spine. Severe Cutaneous Adverse Reactions: Discontinue at the first signs or symptoms of severe cutaneous adverse reactions or other signs of hypersensitivity and consider further evaluation. Cutaneous and Systemic Lupus Erythematosus: Mostly cutaneous; new onset or exacerbation of existing disease; discontinue NEXIUM and refer to specialist for evaluation. Interaction with Clopidogrel: Avoid concomitant use of NEXIUM. Cyanocobalamin (Vitamin B-12) Deficiency: Daily long-term use (e.g., longer than 3 years) may lead to malabsorption or a deficiency of cyanocobalamin.	had heartburn over 3 months. This may be a sign of a more serious condition. frequent wheezing, particularly with heartburn unexplained weight loss nausea or vomiting stomach pain
Contraindications	Known hypersensitivity to substituted benzimidazoles or any component of the formulation. Patients receiving rilpivirine-containing products. Refer to the Contraindications section of the prescribing information for amoxicillin and clarithromycin, when administered in combination with NEXIUM.	trouble or pain swallowing food, vomiting with blood, or bloody or black stools heartburn with lightheadedness, sweating or dizziness chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness frequent chest pain
Drug interactions	There are other antiretroviral drugs which do not result in clinically relevant interactions with esomeprazole. Intervention: Rilpivirine-containing products: Concomitant use with NEXIUM is contraindicated. Atazanavir: See prescribing information for atazanavir for dosing information. Nelfinavir: Avoid concomitant use with NEXIUM. See prescribing information for nelfinavir.	-
Label version	19 December 2025	19 March 2024

Two documents written for two different readers

Written by us

The prescription label is prescribing information addressed to a clinician: indications listed one by one, a dosing table by indication and age, and warnings set out in full. The over-the-counter label is a Drug Facts panel addressed to whoever picks the box off the shelf, and it is written as instructions rather than as evidence.

That is why the two cannot be compared line for line. They are not a long version and a short version of one document; they are answers to two different questions.

The shop label authorises a course, the prescription label treats a condition

Written by us

Nexium 24HR is a 20 mg capsule for adults 18 and over, taken once daily for 14 days against frequent heartburn, meaning heartburn occurring two or more days a week. Its label states not to take more than one capsule a day, and not to take more than one course every four months without asking a doctor.

The prescription Nexium label covers healing of erosive oesophagitis and maintenance of that healing, short-term treatment of heartburn and other GERD symptoms, risk reduction of gastric ulcers associated with anti-inflammatory drugs, Helicobacter pylori eradication in combination with two antibiotics, and long-term treatment of pathological hypersecretory conditions including Zollinger-Ellison syndrome.

Age is where the two are furthest apart

Written by us

The over-the-counter product is for adults only, 18 years and over. The prescription label reaches in the other direction: it covers patients from 12 to 17 for symptomatic GERD, from 1 to 11 years for healing of erosive oesophagitis, and erosive oesophagitis due to acid-mediated GERD in infants from 1 month to under 1 year.

Nothing about the molecule changes across that range. What changes is that a prescriber is choosing the dose.

Neither is a medicine for the moment heartburn starts

Written by us

The shop label says it plainly: not intended for immediate relief, and it may take 1 to 4 days for full effect. That sentence is the reason the product is sold as a 14-day course rather than as something to keep for bad evenings.

The same pharmacology sits behind the prescription version, where durations are longer still and set per indication rather than by the person taking it.

When the shop label says to stop

Written by us

The Drug Facts panel lists what should send someone to a doctor instead of back to the shelf: heartburn lasting over three months, heartburn with lightheadedness, sweating or dizziness, chest or shoulder pain with shortness of breath or pain spreading to the arms, neck or shoulders, frequent chest pain, trouble swallowing, vomiting with blood, bloody or black stools, unexplained weight loss, frequent wheezing with heartburn, nausea or vomiting, and stomach pain.

It also says to stop and ask a doctor if heartburn continues or worsens, if the product is needed for more than 14 days, or if more than one course is needed every four months. This is the part of an over-the-counter label that has no equivalent in the prescription one, because there the same judgement is a clinician's job.

Common questions

Written by us

Is Nexium 24HR just a lower dose of Nexium?: No. Nexium 24HR is 20 mg, and the prescription capsules come in 20 mg and 40 mg, so the same 20 mg exists on both sides. The difference is in the approvals: a 14-day course for frequent heartburn in adults, against a list of conditions treated for durations set per indication.
Can the over-the-counter version be taken long term?: Its label does not authorise that. It sets 14 days, once daily, and says not to use it for more than 14 days or to take more than one course every four months unless a doctor directs it.
Which one is stronger?: That question does not have a label answer. The active ingredient is the same and the over-the-counter strength matches the lower prescription strength. What differs is how long it may be taken and for what.

Sources

Every fact above comes from one of these documents. The date is the effective date of the label version this page was built from.

FDA prescribing information for Nexium
AstraZeneca Pharmaceuticals LP. Label version 74, effective 19 December 2025.
Full label on DailyMed Approval record NDA022101
FDA prescribing information for Nexium 24HR
Haleon US Holdings LLC. Label version 30, effective 19 March 2024.
Full label on DailyMed Approval record NDA204655

Other comparisons in this category

Page last updated: 11 August 2026

Compiled by the HealthyStudy editorial team from FDA source documents. No medical reviewer is credited on this page, because none reviewed it.